Pilot Program for Tobacco Product Manufacturers; Center for Tobacco Products eSubmissions Portal, 8079 [2016-03145]
Download as PDF
Federal Register / Vol. 81, No. 31 / Wednesday, February 17, 2016 / Notices
Dated: February 10, 2016.
Jill Hartzler Warner,
Associate Commissioner for Special Medical
Programs.
[FR Doc. 2016–03152 Filed 2–16–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2016–N–0160]
Pilot Program for Tobacco Product
Manufacturers; Center for Tobacco
Products eSubmissions Portal
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Center for Tobacco
Products (CTP) in the Food and Drug
Administration (FDA) is soliciting
applications from regulated tobacco
product manufacturers to participate in
a voluntary pilot program to help CTP
evaluate a potential new portal, the CTP
eSubmissions Portal (CTP Portal), that is
being designed to improve the process
in connection with providing certain
regulatory submissions electronically to
CTP. CTP plans to accept up to six
participants for the pilot program. The
pilot program is intended to provide
CTP regulatory review staff with an
opportunity to evaluate the CTP Portal,
including its capability for sending and
receiving secure messages and
providing information as to the
documents submitted to it (for example,
receipt date and tracking number).
DATES: Interested parties should submit
an electronic application to participate
in this pilot program by March 2, 2016.
We plan to conduct user testing
beginning on or about March 18, 2016.
See section III of this document for
information on applications for
participation.
SUMMARY:
If you are interested in
participating in this pilot program,
please submit an electronic application
to CTPeSub@fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT: Ann
Staten, Center for Tobacco Products,
Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 75, Rm.
G402, Silver Spring, MD 20993–0002,
ann.staten@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
asabaliauskas on DSK5VPTVN1PROD with NOTICES
ADDRESSES:
I. Background
The Family Smoking Prevention and
Tobacco Control Act of 2009 (Tobacco
Control Act) (Pub. L. 111–31) grants
FDA important authority to regulate the
VerDate Sep<11>2014
19:05 Feb 16, 2016
Jkt 238001
manufacture, marketing, and
distribution of tobacco products to
protect the public health generally and
to reduce tobacco use by minors. Among
its many provisions, the Tobacco
Control Act created requirements for
tobacco product manufacturers and
importers, among others, to submit
certain regulatory documents and
information to FDA, including, but not
limited to, new tobacco product
applications, documents relating to
certain research activities and research
findings, and documents relating to
tobacco product ingredients, including
harmful and potentially harmful
constituents. While certain of these
documents must be submitted
electronically, for others an electronic
format for submission currently is not
required but is strongly encouraged to
facilitate efficiency and timeliness of
data submission and management. Also,
in June 2013, CTP announced a
workshop to obtain public input on
topics related to the potential electronic
submission of tobacco product
applications and other information and
opened a docket for public comment on
this topic. (For more information about
this workshop, please see ‘‘Electronic
Submission of Tobacco Product
Applications and Other Information;
Public Workshop; Request for
Comments’’ (78 FR 34393, June 7, 2013).
CTP has reviewed the input received
from the comments and other sources
and is committed to improving the
processes for providing regulatory
submissions electronically to FDA.
Consequently, CTP is announcing a
pilot program to test the functionality of
the CTP Portal, an electronic submission
and communication tool that should
enhance efficiency, communication, and
timeliness.
II. Pilot Program Participation
The pilot program to evaluate the CTP
Portal is to last approximately 3 months.
During the pilot program, CTP staff will
be available to answer any questions or
concerns that may arise. Pilot program
participants will receive training and
will be asked to submit regulatory
submissions using data provided to
them by CTP for testing purposes. Pilot
program participants also will be asked
to provide written and verbal feedback
during their training and after their
participation in the pilot program is
over. These comments and discussions
will assist CTP in its development of the
CTP Portal. CTP estimates that each
individual participant’s involvement
should take about 15 hours.
CTP is soliciting applications from
regulated tobacco product
manufacturers and, in particular, is
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
8079
interested in hearing from small tobacco
product manufacturers (STPMs) and
tobacco product manufacturers that use
an authorized agent.
III. Applications for Participation
Applications to participate in the
pilot program should be sent
electronically to CTPeSub@fda.hhs.gov.
Applications should include the
following information: Company and
contact name; contact phone number;
contact email address; and whether you
are an STPM. Once applications for
participation are received, FDA will
contact interested applicants to discuss
the pilot program. FDA is seeking a
limited number of participants (no more
than six) to participate in this pilot
program. The pilot program is expected
to last approximately 3 months.
Dated: February 10, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016–03145 Filed 2–16–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2015–N–4462]
Point of Care Prothrombin Time/
International Normalized Ratio Devices
for Monitoring Warfarin Therapy;
Public Workshop; Request for
Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice of public workshop;
request for comments.
ACTION:
The Food and Drug
Administration (FDA) is announcing the
following public workshop entitled
‘‘Point of Care Prothrombin Time/
International Normalized Ratio Devices
for Monitoring Warfarin Therapy.’’ The
purpose of this workshop is to discuss
and receive input from stakeholders
regarding approaches to the analytical
and clinical validation of point of care
(POC) Prothrombin Time/International
Normalized Ratio (PT/INR) in vitro
diagnostic devices for improved clinical
management of warfarin therapy in
addition to describing the FDA’s process
for facilitating the development of safe
and effective POC and patient selftesting PT/INR devices. The goal of the
workshop is to seek and identify
potential solutions to address the
scientific and regulatory challenges
associated with POC PT/INR devices to
ensure safety and effectiveness. The
public workshop on ‘‘Point of Care
SUMMARY:
E:\FR\FM\17FEN1.SGM
17FEN1
Agencies
[Federal Register Volume 81, Number 31 (Wednesday, February 17, 2016)]
[Notices]
[Page 8079]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-03145]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2016-N-0160]
Pilot Program for Tobacco Product Manufacturers; Center for
Tobacco Products eSubmissions Portal
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Center for Tobacco Products (CTP) in the Food and Drug
Administration (FDA) is soliciting applications from regulated tobacco
product manufacturers to participate in a voluntary pilot program to
help CTP evaluate a potential new portal, the CTP eSubmissions Portal
(CTP Portal), that is being designed to improve the process in
connection with providing certain regulatory submissions electronically
to CTP. CTP plans to accept up to six participants for the pilot
program. The pilot program is intended to provide CTP regulatory review
staff with an opportunity to evaluate the CTP Portal, including its
capability for sending and receiving secure messages and providing
information as to the documents submitted to it (for example, receipt
date and tracking number).
DATES: Interested parties should submit an electronic application to
participate in this pilot program by March 2, 2016. We plan to conduct
user testing beginning on or about March 18, 2016. See section III of
this document for information on applications for participation.
ADDRESSES: If you are interested in participating in this pilot
program, please submit an electronic application to
CTPeSub@fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT: Ann Staten, Center for Tobacco
Products, Food and Drug Administration, 10903 New Hampshire Ave., Bldg.
75, Rm. G402, Silver Spring, MD 20993-0002, ann.staten@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The Family Smoking Prevention and Tobacco Control Act of 2009
(Tobacco Control Act) (Pub. L. 111-31) grants FDA important authority
to regulate the manufacture, marketing, and distribution of tobacco
products to protect the public health generally and to reduce tobacco
use by minors. Among its many provisions, the Tobacco Control Act
created requirements for tobacco product manufacturers and importers,
among others, to submit certain regulatory documents and information to
FDA, including, but not limited to, new tobacco product applications,
documents relating to certain research activities and research
findings, and documents relating to tobacco product ingredients,
including harmful and potentially harmful constituents. While certain
of these documents must be submitted electronically, for others an
electronic format for submission currently is not required but is
strongly encouraged to facilitate efficiency and timeliness of data
submission and management. Also, in June 2013, CTP announced a workshop
to obtain public input on topics related to the potential electronic
submission of tobacco product applications and other information and
opened a docket for public comment on this topic. (For more information
about this workshop, please see ``Electronic Submission of Tobacco
Product Applications and Other Information; Public Workshop; Request
for Comments'' (78 FR 34393, June 7, 2013).
CTP has reviewed the input received from the comments and other
sources and is committed to improving the processes for providing
regulatory submissions electronically to FDA. Consequently, CTP is
announcing a pilot program to test the functionality of the CTP Portal,
an electronic submission and communication tool that should enhance
efficiency, communication, and timeliness.
II. Pilot Program Participation
The pilot program to evaluate the CTP Portal is to last
approximately 3 months. During the pilot program, CTP staff will be
available to answer any questions or concerns that may arise. Pilot
program participants will receive training and will be asked to submit
regulatory submissions using data provided to them by CTP for testing
purposes. Pilot program participants also will be asked to provide
written and verbal feedback during their training and after their
participation in the pilot program is over. These comments and
discussions will assist CTP in its development of the CTP Portal. CTP
estimates that each individual participant's involvement should take
about 15 hours.
CTP is soliciting applications from regulated tobacco product
manufacturers and, in particular, is interested in hearing from small
tobacco product manufacturers (STPMs) and tobacco product manufacturers
that use an authorized agent.
III. Applications for Participation
Applications to participate in the pilot program should be sent
electronically to CTPeSub@fda.hhs.gov. Applications should include the
following information: Company and contact name; contact phone number;
contact email address; and whether you are an STPM. Once applications
for participation are received, FDA will contact interested applicants
to discuss the pilot program. FDA is seeking a limited number of
participants (no more than six) to participate in this pilot program.
The pilot program is expected to last approximately 3 months.
Dated: February 10, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-03145 Filed 2-16-16; 8:45 am]
BILLING CODE 4164-01-P